tetano
Editor, Senior Moderator
J Infect Chemother
. 2021 Oct 2;S1341-321X(21)00263-4.
doi: 10.1016/j.jiac.2021.09.014. Online ahead of print.
Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman: A case report
Kyohei Miyamoto[SUP] 1 [/SUP], Yusuke Koizumi[SUP] 2 [/SUP], Shinobu Tamura[SUP] 3 [/SUP], Tsuyoshi Nakashima[SUP] 4 [/SUP], Kaori Kobai[SUP] 5 [/SUP], Rikako Tanaka[SUP] 4 [/SUP], Mami Shibata[SUP] 4 [/SUP], Nozomu Shima[SUP] 4 [/SUP], Shigeki Nemoto[SUP] 4 [/SUP], Nobu Fukumoto[SUP] 4 [/SUP], Seiya Kato[SUP] 4 [/SUP]
Affiliations
Abstract
Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfunction (i.e., cardiovascular and mucocutaneous involvement) and markedly elevated inflammatory markers 2 weeks after recovery from COVID-19. Treatment with intravenous immunoglobulins and corticosteroids resolved her symptoms. On the 13th day, she was discharged from the hospital with no recurrences on follow-up. This study highlights the importance of recognizing this emerging syndrome when treating patients with multiorgan dysfunction after COVID-19.
Keywords: COVID-19; Multisystem inflammatory syndrome; SARS-CoV-2.
. 2021 Oct 2;S1341-321X(21)00263-4.
doi: 10.1016/j.jiac.2021.09.014. Online ahead of print.
Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman: A case report
Kyohei Miyamoto[SUP] 1 [/SUP], Yusuke Koizumi[SUP] 2 [/SUP], Shinobu Tamura[SUP] 3 [/SUP], Tsuyoshi Nakashima[SUP] 4 [/SUP], Kaori Kobai[SUP] 5 [/SUP], Rikako Tanaka[SUP] 4 [/SUP], Mami Shibata[SUP] 4 [/SUP], Nozomu Shima[SUP] 4 [/SUP], Shigeki Nemoto[SUP] 4 [/SUP], Nobu Fukumoto[SUP] 4 [/SUP], Seiya Kato[SUP] 4 [/SUP]
Affiliations
- PMID: 34620535
- DOI: 10.1016/j.jiac.2021.09.014
Abstract
Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfunction (i.e., cardiovascular and mucocutaneous involvement) and markedly elevated inflammatory markers 2 weeks after recovery from COVID-19. Treatment with intravenous immunoglobulins and corticosteroids resolved her symptoms. On the 13th day, she was discharged from the hospital with no recurrences on follow-up. This study highlights the importance of recognizing this emerging syndrome when treating patients with multiorgan dysfunction after COVID-19.
Keywords: COVID-19; Multisystem inflammatory syndrome; SARS-CoV-2.